Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer


Growth Equity | Alive

Total Raised


Last Raised

$980K | 13 yrs ago

About Dee Pharmaceuticals

Provider of branded prescription pharmaceuticals. The company specializes in the sale and marketing of branded prescription pharmaceuticals with particular focus on the substance abuse market. Its principal product is an oral solution of methadone hydrochloride used to treat opioid drug addiction and as an analgesic for moderate to severe pain.

Dee Pharmaceuticals Headquarter Location

Redwither Tower Redwither Business Park

Wrexham, LL13 9XT,

United Kingdom

01 978 661 993

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.